p53 - european urology 53 (2008) 858863 859 [5] Averette...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
[5] Averette HE, Steren A, Nguyen HN. Screening in gyneco- logic cancers. Cancer 1993;72(3 Suppl.):1043–9. Tommaso Cai* Nicola Mondaini Riccardo Bartoletti Department of Urology, University of Florence, Florence, Italy Sandra Mazzoli STDs Centre, Santa Maria Annunziata Hospital, Florence, Italy *Corresponding author. Department of Urology, University of Florence, Via dell’Antella, 58, 50011 Bagno a Ripoli, Florence, Italy. Tel. +390552496347; Fax: +390552496452. E-mail address: ktommy@libero.it (T. Cai) September 25, 2007 Published online ahead of print on October 2, 2007 doi: 10.1016/j.eururo.2007.09.041 DOI of original article: 10.1016/j.eururo.2006.11.017 Reply to Tommaso Cai, Nicola Mondaini, Riccardo Bartoletti and Sandra Mazzoli’s Letter to the Editor re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer. Eur Urol 2007;52:464–9 The findings of Cai et al indeed are interesting and
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.
Ask a homework question - tutors are online